Data and Sources

by

Purpose

This section defines the data streams, documentary evidence, and analytical sources that inform the assessment of ecological collapse, mechanistic drivers, and restoration planning.

The goal is transparency: every major claim in subsequent sections is anchored in identifiable data, with clear distinction between measured, inferred, and speculative layers.

—

1. Primary Data Sources

Primary sources are direct measurements or contemporaneous records generated from the user’s clinical, microbiome, or biological environment.

1.1 Shotgun Metagenomics

  • Thorne/Onegevity shotgun metagenomic sequencing

    • * August 2024 (baseline collapse state)

    * September 2025 (post-intervention comparison)

  • Provides:

    • * Relative abundance at phylum/genus/species

    * Functional pathway predictions

    * Pathobiont overgrowth diagnostics

    * SCFA pathways, mucin degradation markers

  • Limitations:

    • * Does not measure absolute cell counts

    * Species inference can be noisy at low abundance

    * Does not measure metabolites directly

    1.2 Clinical Lab Testing

  • CBC, CMP, CRP, ESR
  • Iron studies (post-infusion effects)
  • Autoimmune markers
  • Thyroid panel
  • Serum B12, folate, vitamin D
  • IgE / MCAS-related markers
  • Intermittent liver enzyme panels tied to bile acid dysregulation

    • 1.3 Direct Symptom Logs

  • Daily timing logs (fatigue, pain distribution, RA swelling, GI function)
  • Reaction logs tied to interventions
  • Notes on abdominal neuro-motility sensations, right upper-quadrant discomfort, autonomic shifts
  • Protocol days vs non-protocol days for signal separation
  • Used for correlating ecological shifts with functional response

    • 1.4 Historical Clinical Records

  • Helminthic therapy: multi-year remission baseline
  • Iron infusion events and post-infusion inflammatory cascades
  • Timeline of collapse (late 2023 → early 2024)
  • Prior autoimmune baseline for comparison

    • —

    2. Secondary Data Sources

    These are synthesized from external research and used to interpret primary data.

    2.1 Published Scientific Literature

  • Work on ecological collapse, dysbiosis stability, overgrowth dynamics
  • Bile acid dysregulation and mucosal barrier injury
  • Endotoxin signaling in pathobiont-dominant ecosystems
  • Mitochondrial dysfunction as downstream effect of ecological stress
  • Probiotic strain function (mechanisms, not consumer claims)
  • SCFA fermentation, butyrate pathways, mucin degradation
  • Helminthic immunomodulation literature
  • Peptide and barrier-repair clinical research (KPV, larazotide, BPC-157, etc.)
  • All citations placed in relevant chapters rather than aggregated here

    • 2.2 Mechanistic Reference Sheets

    Your consolidated spreadsheets capturing:

  • Each layer’s biological target
  • Each intervention’s mechanism (e.g., anti-inflammatory, demulcent, trophic shift, SCFA support)
  • Pathway mapping (what each supplement actually does)
  • Gate-layer completeness checking

    • These spreadsheets anchor the Gate-1 restoration plan and ensure that selected interventions meet all defined layer requirements.

    2.3 Functional Scores (Derived)

  • Diversity score
  • Proteobacteria burden
  • Mucin degradation markers
  • SCFA pathway completeness
  • Aerobic vs anaerobic functional imbalance

    • These are derived scores, not clinical values, extracted from metagenomic interpretation tools.

    —

    3. Internal Synthetic Data

    Generated by combining multiple datasets to create usable structures for planning.

    3.1 Collapse Trajectory Model

    Integrates:

  • Metagenomics
  • Timeline logs
  • Helminthic loss-of-function period
  • RA breakthrough events
  • Symptom clusters

    • Used to categorize the collapse into phases and to identify stability points.

    3.2 Barrier-Centered Restoration Framework

    Constructed from:

  • Mechanistic spreadsheet
  • Gate-layer definitions
  • Failure analysis of the DBKR attempt

    • Defines:

  • Gate 1 baseline intervention
  • Sequence rules
  • Timing rules
  • Safety boundaries
  • Conditions for advancing to next Gate

    • 3.3 Ecological Architecture Map

  • Identifies trophic positions
  • Maps butyrate-producers vs pathobionts
  • Bile acid conversion dynamics
  • Host-microbial interface stressors
  • Determines what is feasible in a damaged ecosystem vs post-restoration ecosystem

    • —

    4. Data Integrity and Limitations

    Transparency regarding what is known vs estimated vs uncertain.

    4.1 Measurement Limits

  • Shotgun metagenomics cannot measure:

    • * Mitochondrial status

    * Actual metabolite levels

    * Endotoxin concentration

    * Motility status

  • Clinical labs do not capture ecological architecture directly.

    • 4.2 Interpretive Limits

  • Some symptom clusters may overlap (e.g., bile acid irritation vs small bowel fermentation).
  • Temporal confounders exist (e.g., RA flare superimposed on microbial collapse).
  • Motility signals may represent mixed neural and inflammatory drivers.

    • 4.3 Assumptions

    Explicitly noted in each chapter when used.

    Examples:

  • “Collapse stability” is inferred from unchanged metagenomic pattern + constant symptoms.
  • Butyrate pathway loss is inferred from both functional prediction and symptom pattern.
  • Bile acid recirculation overload is inferred from symptom cluster + motility + RUQ discomfort.

    • —

    5. How This Section Is Used

  • Establishes which data streams are authoritative vs contextual
  • Grounds all conclusions in documented evidence
  • Separates observed data from model-based reasoning
  • Supports reproducibility of the restoration plan
  • Prevents overfitting to any single source (e.g., metagenomics only)